Effects of insulin+glucose pretreatment on bupivacaine cardiotoxicity in rats
- PMID: 28565972
- DOI: 10.1177/0960327117712384
Effects of insulin+glucose pretreatment on bupivacaine cardiotoxicity in rats
Abstract
A mistaken overdose of bupivacaine into systemic circulation may cause severe cardiovascular side effects. The aim of this study was to assess the effects of pretreatment with combined intra venous lipid emulsion (ILE) and high-dose insulin therapy against cardiotoxicity caused by bupivacaine intoxication. The rats were divided into the following three groups: Group B received a saline pretreatment plus a bupivacaine, group L received ILE pretreatment plus a bupivacaine, and in group I, insulin with glucose was infused intravenously, plus ILE pretreatment plus a bupivacaine. The electrocardiogram tracing, invasive arterial pressure, and heart rate (HR) of rats were monitored continuously. Arterial blood gas analysis was performed in all groups. Arterial blood gas analysis revealed that the baseline pH, PaO2, and PaCO2 values were similar between groups ( p > 0.05). Widening of Q, R, and S wave complex was found 46.8 ± 16.7, 92.0 ± 5.80, and 106.5 ± 17.9 s after initiation of bupivacaine infusion in groups B, L, and I, respectively. Time elapsed until 25% reduction of HR 127.3 ± 17.7, 248.4 ± 34.1, and 260.1 ± 51.3 s for groups B, L, and I, and 25% reduction of mean arterial pressure 107.6 ± 14.1, 253.2 ± 36.3, and 292 ± 57.7 s for groups B, L, and I, respectively. Arrhythmia was observed after 142.2 ± 27.5, 180.7 ± 17.8, and 190.7 ± 19.2 s for groups B, L, and I, respectively. Finally, asystole occurred after 560.1 ± 76.4, 782.4 ± 63.0, and 882.5 ± 105.1 s for groups B, L, and I, respectively. This finding indicates that the survival time of rats administered pretreatment with ILE plus insulin+glucose and those given ILE was observed to be longer.
Keywords: Bupivacaine; cardiotoxicity; insulin; intra venous lipid emulsion (ILE).
Comment in
-
Bupivacaine-induced cardiotoxicity and lipid emulsion.Hum Exp Toxicol. 2019 Apr;38(4):494-495. doi: 10.1177/0960327118819042. Epub 2018 Dec 16. Hum Exp Toxicol. 2019. PMID: 30556419 No abstract available.
Similar articles
-
Effects of Remifentanil Pretreatment on Bupivacaine Cardiotoxicity in Rats.Cardiovasc Toxicol. 2018 Feb;18(1):56-62. doi: 10.1007/s12012-017-9413-3. Cardiovasc Toxicol. 2018. PMID: 28540470
-
Giving Priority to Lipid Administration Can Reduce Lung Injury Caused by Epinephrine in Bupivacaine-Induced Cardiac Depression.Reg Anesth Pain Med. 2016 Jul-Aug;41(4):469-76. doi: 10.1097/AAP.0000000000000424. Reg Anesth Pain Med. 2016. PMID: 27281728
-
Effects of dexmedetomidine pretreatment on bupivacaine cardiotoxicity in rats.Reg Anesth Pain Med. 2009 Nov-Dec;34(6):565-8. doi: 10.1097/aap.0b013e3181bfbe35. Reg Anesth Pain Med. 2009. PMID: 19916248
-
Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection.J Pharm Pharm Sci. 2017;20(1):329-331. doi: 10.18433/J30D2V. J Pharm Pharm Sci. 2017. PMID: 29145932 Review.
-
Efficacy of lipid emulsion therapy in treating cardiotoxicity from diphenhydramine ingestion: a review and analysis of case reports.Clin Toxicol (Phila). 2022 May;60(5):550-558. doi: 10.1080/15563650.2022.2038187. Epub 2022 Feb 16. Clin Toxicol (Phila). 2022. PMID: 35171053 Review.
Cited by
-
Local anesthetic systemic toxicity: current perspectives.Local Reg Anesth. 2018 Aug 8;11:35-44. doi: 10.2147/LRA.S154512. eCollection 2018. Local Reg Anesth. 2018. PMID: 30122981 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical